Tower Research Capital (TRC)’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,478
Closed -$1K 6580
2023
Q1
$1K Buy
+2,478
New +$1.97K ﹤0.01% 5725
2022
Q2
Sell
-1,092
Closed -$8K 6832
2022
Q1
$8K Buy
1,092
+284
+35% +$1.65K ﹤0.01% 4649
2021
Q4
$5K Buy
808
+117
+17% +$1.2K ﹤0.01% 5240
2021
Q3
$8K Sell
691
-1,388
-67% -$19.2K ﹤0.01% 4594
2021
Q2
$39K Buy
2,079
+2,019
+3,365% +$37.6K ﹤0.01% 3249
2021
Q1
$1K Buy
+60
New +$1.52K ﹤0.01% 5253
2017
Q4
Sell
-9
Closed -$4K 4283
2017
Q3
$4K Sell
9
-20
-69% -$10.4K ﹤0.01% 3428
2017
Q2
$17K Buy
+29
New +$17K ﹤0.01% 1324
2016
Q2
Sell
-4
Closed -$2K 5158
2016
Q1
$2K Buy
4
+3
+300% +$1.12K ﹤0.01% 3489
2015
Q4
$1K Sell
1
-1
-50% -$723 ﹤0.01% 4213
2015
Q3
$3K Buy
+2
New +$3.06K ﹤0.01% 3198
2015
Q2
Sell
-2
Closed -$2K 5245
2015
Q1
$2K Buy
+2
New +$2.37K ﹤0.01% 3862
2014
Q4
Sell
-18
Closed -$24K 4893
2014
Q3
$24K Buy
18
+12
+200% +$17.2K ﹤0.01% 2168
2014
Q2
$9K Buy
6
+3
+100% +$5.71K ﹤0.01% 2467
2014
Q1
$6K Sell
3
-2
-40% -$5.12K ﹤0.01% 3148
2013
Q4
$11K Buy
+5
New +$10.8K ﹤0.01% 2928

Other funds holding VYNT